Skip to main content
Caplight Logo









UNOMR AG

UNOMR AG

Private
ZurichHealthcare & Life Scienceshttps://unomr.com/

Last Round

Pre Seed

Feb 27, 2026

Total Funding Raised

$507,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

UNOMR AG is a biotechnology company developing a single-molecule protein analysis platform based on nanopore technology for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Sensors, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

single-molecule protein sequencingproteomics platformnanopore protein sequencingnext-gen proteomicsinterface nanoporeprotein modification analysisTechBioAI-powered proteomicsiNPglycosylation analysisbiotech equipmentdrug discovery toolanalysis as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UNOMR AG Comparables

Compare UNOMR AG with similar companies based on industry and business-model similarity.

UNOMR AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Primary Bioscience
84%
Erisyon
81%
Glyphic Biotechnologies
79%

UNOMR AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 27, 2026
GrantJan 5, 2026
GrantApr 15, 2025
GrantFeb 20, 2025
GrantDec 16, 2024
Grant
Apr 1, 2024

Key People

Founding team and executive leadership

Julia Wagner

Co-founder & COO

Founding Team

Julian Hengsteler

Co-Founder, CTO

Founding Team

Til Schlotter

Co-founder & CEO

Founding Team

UNOMR AG Investors

Notable investors and investment history

UNOMR AG investors
InvestorRounds
Gebert Rüf StiftungGrant
InnosuisseGrant
BRIDGEGrant
Venture KickGrant
SPRINDGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 174% MoM.

  • Jan 5, 2026

    Received grant funding from SPRIND.

UNOMR AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

UNOMR AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about UNOMR AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range8
Year Founded2025
Last FundingFeb 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?